poster abstractRegression models have been widely studied to investigate whether multimodal neuroimaging measures can be used as effective biomarkers for predicting cognitive outcomes in the study of Alzheimer's Disease (AD). Most existing models overlook the interrelated structures either within neuroimaging measures or between cognitive outcomes, and thus may have limited power to yield optimal solutions. To address this issue, we propose to incorporate an L21 norm and/or a group L21 norm (G21 norm) in the regression models. Using ADNI-1 and ADNI-GO/2 data, we apply these models to examining the ability of structural MRI and AV-45 PET scans for predicting cognitive measures including ADAS and RAVLT scores. We focus our analyses on the par...
Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders among the elderly pop...
International audienceVarious machine learning approaches have been developed for predicting progres...
The concept of Mild Cognitive Impairment (MCI) is used to describe the early stages of Alzheimer’s d...
Alzheimer’s disease (AD) is the most common form of de-mentia that causes progressive impairment of ...
Predicting cognitive performance of subjects from their magnetic resonance imaging (MRI) measures an...
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by pro-gressive impairment of...
Predicting cognitive performance of subjects from their magnetic resonance imaging (MRI) measures an...
For patients with mild cognitive impairment (MCI), the likelihood of progression to probable Alzheim...
Abstract. Traditional neuroimaging studies in Alzheimer’s disease (AD) typically employ independent ...
MotivationRecent advances in brain imaging and high-throughput genotyping techniques enable new appr...
Mild cognitive impairment is a preclinical stage of Alzheimer's disease (AD). For effective treatmen...
Alzheimer's Disease (AD) is a chronic neurodegenerative disease that severely impacts patients' thin...
Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) is a neuropsychological tool that...
International audienceVarious machine learning methods have been proposed for predicting progression...
Motivation: Recent advances in brain imaging and high-throughput genotyping techniques enable new ap...
Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders among the elderly pop...
International audienceVarious machine learning approaches have been developed for predicting progres...
The concept of Mild Cognitive Impairment (MCI) is used to describe the early stages of Alzheimer’s d...
Alzheimer’s disease (AD) is the most common form of de-mentia that causes progressive impairment of ...
Predicting cognitive performance of subjects from their magnetic resonance imaging (MRI) measures an...
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by pro-gressive impairment of...
Predicting cognitive performance of subjects from their magnetic resonance imaging (MRI) measures an...
For patients with mild cognitive impairment (MCI), the likelihood of progression to probable Alzheim...
Abstract. Traditional neuroimaging studies in Alzheimer’s disease (AD) typically employ independent ...
MotivationRecent advances in brain imaging and high-throughput genotyping techniques enable new appr...
Mild cognitive impairment is a preclinical stage of Alzheimer's disease (AD). For effective treatmen...
Alzheimer's Disease (AD) is a chronic neurodegenerative disease that severely impacts patients' thin...
Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) is a neuropsychological tool that...
International audienceVarious machine learning methods have been proposed for predicting progression...
Motivation: Recent advances in brain imaging and high-throughput genotyping techniques enable new ap...
Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders among the elderly pop...
International audienceVarious machine learning approaches have been developed for predicting progres...
The concept of Mild Cognitive Impairment (MCI) is used to describe the early stages of Alzheimer’s d...